Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q48672273 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241120235933.0 | ||
008 | 241120nneanz||abbn n and d | ||
035 | ‡a (WKP)Q48672273 | ||
024 | ‡a 0000-0001-9680-4027 ‡2 orcid | ||
024 | ‡a 36113120400 ‡2 scopus | ||
035 | ‡a (OCoLC)Q48672273 | ||
100 | 0 | ‡a Sara Duarte-Silva ‡9 ast ‡9 es ‡9 sl | |
375 | ‡a 2 ‡2 iso5218 | ||
400 | 0 | ‡a Sara Duarte-Silva ‡c researcher ‡9 en | |
400 | 0 | ‡a Sara Duarte-Silva ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment | ||
670 | ‡a Author's Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease | ||
670 | ‡a Author's Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease | ||
670 | ‡a Author's Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease. | ||
670 | ‡a Author's Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis | ||
670 | ‡a Author's Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease | ||
670 | ‡a Author's Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease (MJD/SCA3). | ||
670 | ‡a Author's Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts | ||
670 | ‡a Author's Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells | ||
670 | ‡a Author's IP3 R2 null mice display a normal acquisition of somatic and neurological development milestones | ||
670 | ‡a Author's Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease | ||
670 | ‡a Author's Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease | ||
670 | ‡a Author's Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome | ||
670 | ‡a Author's Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products | ||
670 | ‡a Author's Neuroprotective effects of creatine in the CMVMJD135 mouse model of spinocerebellar ataxia type 3. | ||
670 | ‡a Author's Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy | ||
670 | ‡a Author's Pharmacological Therapies for Machado-Joseph Disease. | ||
670 | ‡a Author's Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease | ||
670 | ‡a Author's Selective impact of Tau loss on nociceptive primary afferents and pain sensation | ||
670 | ‡a Author's Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease | ||
670 | ‡a Author's Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease | ||
909 | ‡a (scopus) 36113120400 ‡9 1 | ||
909 | ‡a (orcid) 0000000196804027 ‡9 1 | ||
919 | ‡a pharmacologicaltherapiesformachadojosephdisease ‡A Pharmacological Therapies for Machado-Joseph Disease. ‡9 1 | ||
919 | ‡a tauroursodeoxycholicacidimprovesmotorsymptomsinamousemodelofparkinsonsdisease ‡A Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease ‡9 1 | ||
919 | ‡a serotonergicsignallingsuppressesataxin3aggregationandneurotoxicityinanimalmodelsofmachadojosephdisease ‡A Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease ‡9 1 | ||
919 | ‡a selectiveimpactoftaulossonnociceptiveprimaryafferentsandpainsensation ‡A Selective impact of Tau loss on nociceptive primary afferents and pain sensation ‡9 1 | ||
919 | ‡a preclinicalevidencesupportingearlyinitiationofcitalopramtreatmentinmachadojosephdisease ‡A Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease ‡9 1 | ||
919 | ‡a neurotoxiceffectsofmptponmousecerebralcortexmodulationofneuroinflammationasaneuroprotectivestrategy ‡A Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy ‡9 1 | ||
919 | ‡a neuroprotectiveeffectsofcreatineinthecmvmjd135mousemodelofspinocerebellarataxiatype3 ‡A Neuroprotective effects of creatine in the CMVMJD135 mouse model of spinocerebellar ataxia type 3. ‡9 1 | ||
919 | ‡a motoruncoordinationandneuropathologyinatransgenicmousemodelofmachadojosephdiseaselackingintranuclearinclusionsandataxin3cleavageproducts ‡A Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products ‡9 1 | ||
919 | ‡a monoaminedeficitsinthebrainofmethylcpgbindingprotein2nullmicesuggesttheinvolvementofthecerebralcortexinearlystagesofrettsyndrome ‡A Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome ‡9 1 | ||
919 | ‡a lithiumchloridetherapyfailstoimprovemotorfunctioninatransgenicmousemodelofmachadojosephdisease ‡A Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease ‡9 1 | ||
919 | ‡a limitedeffectofchronicvalproicacidtreatmentinamousemodelofmachadojosephdisease ‡A Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease ‡9 1 | ||
919 | ‡a ip3r2nullmicedisplayanormalacquisitionofsomaticandneurologicaldevelopmentmilestones ‡A IP3 R2 null mice display a normal acquisition of somatic and neurological development milestones ‡9 1 | ||
919 | ‡a dominantnegativeeffectofpolyglutamineexpansionperturbsnormalfunctionofataxin3inneuronalcells ‡A Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells ‡9 1 | ||
919 | ‡a discoveryoftherapeuticapproachesforpolyglutaminediseasesasummaryofrecentefforts ‡A Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts ‡9 1 | ||
919 | ‡a differentialmtdnadamagepatternsinatransgenicmousemodelofmachadojosephdiseasemjdsca3 ‡A Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease (MJD/SCA3). ‡9 1 | ||
919 | ‡a differentialmtdnadamagepatternsinatransgenicmousemodelofmachadojosephdisease ‡A Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease ‡9 1 | ||
919 | ‡a deficiencyinclassicalnonhomologousendjoiningmediatedrepairoftranscribedgenesislinkedtosca3pathogenesis ‡A Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis ‡9 1 | ||
919 | ‡a combinedtherapywith1000tordependentandindependentautophagyinducerscausesneurotoxicityinamousemodelofmachadojosephdisease ‡A Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease. ‡9 1 | ||
919 | ‡a citalopramreducesaggregationofatxn3inayactransgenicmousemodelofmachadojosephdisease ‡A Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease ‡9 1 | ||
919 | ‡a chronictreatmentwith17dmagimprovesbalanceandcoordinationinanewmousemodelofmachadojosephdisease ‡A Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease ‡9 1 | ||
919 | ‡a absenceoftautriggersagedependentsciaticnervemorphofunctionaldeficitsandmotorimpairment ‡A Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment ‡9 1 | ||
946 | ‡a a ‡9 1 | ||
996 | ‡2 DNB|101139300X | ||
996 | ‡2 ISNI|0000000480994729 | ||
996 | ‡2 PTBNP|1648622 | ||
996 | ‡2 NSK|000310189 | ||
996 | ‡2 LC|n 2006215192 | ||
996 | ‡2 NUKAT|n 2002068086 | ||
996 | ‡2 PTBNP|1600130 | ||
996 | ‡2 NTA|069710848 | ||
996 | ‡2 ISNI|0000000070135075 | ||
996 | ‡2 PTBNP|1918404 | ||
996 | ‡2 ISNI|0000000069389246 | ||
996 | ‡2 J9U|987007339671705171 | ||
996 | ‡2 BNE|XX5053519 | ||
996 | ‡2 ISNI|0000000399508164 | ||
996 | ‡2 LC|n 80151357 | ||
996 | ‡2 PTBNP|78099 | ||
996 | ‡2 LC|n 2009022746 | ||
996 | ‡2 ISNI|000000039033863X | ||
996 | ‡2 DNB|1066878765 | ||
996 | ‡2 PTBNP|186365 | ||
996 | ‡2 PTBNP|1188751 | ||
996 | ‡2 BIBSYS|90365691 | ||
996 | ‡2 ISNI|0000000066497946 | ||
996 | ‡2 RERO|A003832012 | ||
996 | ‡2 PTBNP|111237 | ||
996 | ‡2 RERO|A027492983 | ||
996 | ‡2 SUDOC|268596174 | ||
996 | ‡2 LC|n 2006181260 | ||
996 | ‡2 ISNI|000000043081323X | ||
996 | ‡2 ISNI|0000000107787967 | ||
996 | ‡2 LC|no2010028321 | ||
996 | ‡2 BIBSYS|90123753 | ||
996 | ‡2 DNB|1193107237 | ||
996 | ‡2 ISNI|0000000495700228 | ||
996 | ‡2 PTBNP|1716657 | ||
996 | ‡2 ISNI|0000000117210811 | ||
996 | ‡2 LC|no2006030252 | ||
996 | ‡2 PTBNP|1661555 | ||
996 | ‡2 LC|n 2024245470 | ||
996 | ‡2 PTBNP|1595340 | ||
996 | ‡2 PTBNP|284990 | ||
996 | ‡2 SUDOC|181053381 | ||
996 | ‡2 PTBNP|1680343 | ||
996 | ‡2 PTBNP|1681097 | ||
996 | ‡2 BLBNB|001490775 | ||
996 | ‡2 ISNI|0000000070899788 | ||
996 | ‡2 ISNI|0000000067468661 | ||
996 | ‡2 PTBNP|77332 | ||
996 | ‡2 DNB|1158904533 | ||
996 | ‡2 BNE|XX1133645 | ||
996 | ‡2 ISNI|0000000084572532 | ||
996 | ‡2 BLBNB|000538386 | ||
996 | ‡2 LC|n 2016247592 | ||
996 | ‡2 SUDOC|257640223 | ||
996 | ‡2 DNB|1159101795 | ||
996 | ‡2 ISNI|0000000084545657 | ||
996 | ‡2 LC|no2005015402 | ||
996 | ‡2 PTBNP|1353288 | ||
996 | ‡2 PTBNP|1240524 | ||
996 | ‡2 ISNI|0000000495730072 | ||
996 | ‡2 PTBNP|1408393 | ||
996 | ‡2 SUDOC|183172205 | ||
996 | ‡2 NII|DA01588338 | ||
996 | ‡2 ISNI|0000000068717498 | ||
996 | ‡2 PTBNP|1872043 | ||
996 | ‡2 BLBNB|000200858 | ||
996 | ‡2 LC|n 2020184010 | ||
996 | ‡2 ISNI|0000000077837002 | ||
996 | ‡2 PTBNP|1396861 | ||
996 | ‡2 DNB|1200357981 | ||
996 | ‡2 ISNI|0000000081654946 | ||
996 | ‡2 ISNI|0000000068305629 | ||
996 | ‡2 NUKAT|n 01033622 | ||
996 | ‡2 PTBNP|962148 | ||
996 | ‡2 PTBNP|1367948 | ||
996 | ‡2 PTBNP|1770011 | ||
996 | ‡2 PTBNP|1464236 | ||
996 | ‡2 PTBNP|216279 | ||
996 | ‡2 SUDOC|067310516 | ||
996 | ‡2 PTBNP|1449337 | ||
996 | ‡2 BIBSYS|7005600 | ||
996 | ‡2 NTA|071489223 | ||
996 | ‡2 PTBNP|115745 | ||
996 | ‡2 DNB|1057623563 | ||
996 | ‡2 ISNI|0000000453081350 | ||
996 | ‡2 PLWABN|9810581604205606 | ||
996 | ‡2 LC|no2024092169 | ||
996 | ‡2 SUDOC|13453848X | ||
996 | ‡2 PTBNP|1156695 | ||
996 | ‡2 PTBNP|1730175 | ||
996 | ‡2 PTBNP|132423 | ||
996 | ‡2 SUDOC|257935916 | ||
996 | ‡2 PTBNP|821961 | ||
996 | ‡2 PTBNP|955438 | ||
996 | ‡2 ISNI|0000000053434161 | ||
996 | ‡2 SUDOC|274618575 | ||
996 | ‡2 PTBNP|1667558 | ||
996 | ‡2 ISNI|0000000034890903 | ||
996 | ‡2 DNB|1262488192 | ||
996 | ‡2 LC|n 88123131 | ||
996 | ‡2 BNC|981058609886906706 | ||
996 | ‡2 ISNI|0000000086222923 | ||
996 | ‡2 SUDOC|223538019 | ||
996 | ‡2 LC|nb2003050872 | ||
996 | ‡2 PTBNP|1513036 | ||
996 | ‡2 LC|n 81096743 | ||
996 | ‡2 PTBNP|1785127 | ||
996 | ‡2 BAV|495_255310 | ||
996 | ‡2 ISNI|0000000078142069 | ||
996 | ‡2 PTBNP|222811 | ||
996 | ‡2 PTBNP|1175924 | ||
996 | ‡2 DNB|1278684980 | ||
996 | ‡2 ISNI|0000000431467113 | ||
996 | ‡2 NSK|000459157 | ||
996 | ‡2 ISNI|0000000066643085 | ||
996 | ‡2 PTBNP|1815068 | ||
996 | ‡2 LC|n 80094384 | ||
996 | ‡2 J9U|987007454328305171 | ||
996 | ‡2 LC|nb2020002115 | ||
996 | ‡2 PTBNP|1750517 | ||
996 | ‡2 LIH|LNB:CON_z_;=B_w_ | ||
996 | ‡2 BIBSYS|9002246 | ||
996 | ‡2 PTBNP|1756418 | ||
996 | ‡2 PTBNP|1613592 | ||
996 | ‡2 DNB|1070018309 | ||
996 | ‡2 J9U|987007456720705171 | ||
996 | ‡2 ISNI|0000000069310614 | ||
996 | ‡2 PTBNP|159858 | ||
996 | ‡2 DNB|1146907796 | ||
996 | ‡2 ISNI|0000000077871550 | ||
996 | ‡2 NKC|xx0193685 | ||
996 | ‡2 CAOONL|ncf11576151 | ||
996 | ‡2 LC|no2013131032 | ||
996 | ‡2 PTBNP|1721040 | ||
996 | ‡2 PTBNP|1406579 | ||
996 | ‡2 ISNI|0000000113991526 | ||
996 | ‡2 ISNI|0000000084190833 | ||
996 | ‡2 DNB|1037812247 | ||
996 | ‡2 NTA|069149461 | ||
996 | ‡2 ISNI|0000000070535634 | ||
996 | ‡2 PTBNP|203621 | ||
996 | ‡2 PTBNP|1146655 | ||
996 | ‡2 ISNI|0000000046703415 | ||
996 | ‡2 ISNI|0000000116991679 | ||
996 | ‡2 NUKAT|n 2010153984 | ||
996 | ‡2 PTBNP|264125 | ||
996 | ‡2 SUDOC|122558022 | ||
996 | ‡2 J9U|987007273381905171 | ||
996 | ‡2 PTBNP|1446116 | ||
996 | ‡2 BIBSYS|13060935 | ||
996 | ‡2 ISNI|0000000068479661 | ||
996 | ‡2 BNCHL|10000000000000000037475 | ||
996 | ‡2 NII|DA03780223 | ||
996 | ‡2 J9U|987007379067005171 | ||
996 | ‡2 LC|n 2014024447 | ||
996 | ‡2 ISNI|0000000073206027 | ||
996 | ‡2 NTA|100530117 | ||
996 | ‡2 LC|n 98107135 | ||
996 | ‡2 SZ|1246776618 | ||
996 | ‡2 SUDOC|112646247 | ||
996 | ‡2 PTBNP|103419 | ||
996 | ‡2 RERO|A000149978 | ||
996 | ‡2 LC|n 88157607 | ||
996 | ‡2 BIBSYS|1008782 | ||
996 | ‡2 PTBNP|225904 | ||
996 | ‡2 JPG|500099760 | ||
996 | ‡2 SUDOC|25447635X | ||
996 | ‡2 RERO|A011064034 | ||
996 | ‡2 BNCHL|10000000000000000096447 | ||
996 | ‡2 BLBNB|001556818 | ||
996 | ‡2 BLBNB|001544322 | ||
996 | ‡2 NUKAT|n 2016000716 | ||
996 | ‡2 PTBNP|1925040 | ||
996 | ‡2 DNB|1236729978 | ||
996 | ‡2 SUDOC|249929791 | ||
996 | ‡2 PTBNP|93195 | ||
996 | ‡2 NTA|428344739 | ||
996 | ‡2 ISNI|0000000116952100 | ||
996 | ‡2 PTBNP|34609 | ||
996 | ‡2 PTBNP|1571509 | ||
996 | ‡2 CAOONL|ncf11569407 | ||
996 | ‡2 J9U|987007323224205171 | ||
996 | ‡2 J9U|987012501466505171 | ||
996 | ‡2 PTBNP|248168 | ||
996 | ‡2 ISNI|0000000067129328 | ||
996 | ‡2 CAOONL|ncf11476462 | ||
996 | ‡2 ISNI|0000000070604919 | ||
996 | ‡2 PTBNP|1694888 | ||
996 | ‡2 ISNI|0000000069494839 | ||
996 | ‡2 DNB|1157058396 | ||
996 | ‡2 ISNI|000000011654369X | ||
996 | ‡2 ISNI|0000000070988246 | ||
996 | ‡2 ISNI|0000000082025551 | ||
996 | ‡2 ISNI|0000000069115632 | ||
996 | ‡2 NUKAT|n 2008147605 | ||
996 | ‡2 PTBNP|24847 | ||
996 | ‡2 BLBNB|000352684 | ||
996 | ‡2 SUDOC|149942885 | ||
996 | ‡2 BLBNB|000456173 | ||
996 | ‡2 PTBNP|1179153 | ||
996 | ‡2 DNB|1246776618 | ||
996 | ‡2 ISNI|0000000067213714 | ||
996 | ‡2 DNB|1339061732 | ||
996 | ‡2 ISNI|0000000094439364 | ||
996 | ‡2 DNB|1256776750 | ||
996 | ‡2 ISNI|0000000068403982 | ||
996 | ‡2 PTBNP|1401176 | ||
996 | ‡2 LC|no2012157617 | ||
996 | ‡2 NTA|353739774 | ||
996 | ‡2 PTBNP|209226 | ||
996 | ‡2 SUDOC|274457989 | ||
996 | ‡2 ISNI|0000000434273779 | ||
996 | ‡2 BLBNB|001443283 | ||
996 | ‡2 BNF|15046395 | ||
996 | ‡2 ISNI|000000010509776X | ||
996 | ‡2 ISNI|0000000069613586 | ||
996 | ‡2 LC|n 2017226766 | ||
996 | ‡2 CAOONL|ncf11681145 | ||
996 | ‡2 LC|n 98096627 | ||
996 | ‡2 NUKAT|n 2014052889 | ||
996 | ‡2 BAV|495_330778 | ||
996 | ‡2 SUDOC|19628239X | ||
996 | ‡2 PTBNP|1809860 | ||
996 | ‡2 BLBNB|000444783 | ||
996 | ‡2 PLWABN|9811568977105606 | ||
996 | ‡2 SUDOC|164092617 | ||
996 | ‡2 ICCU|CUBV145869 | ||
996 | ‡2 PTBNP|1437328 | ||
996 | ‡2 ISNI|000000006859220X | ||
996 | ‡2 ISNI|000000007001269X | ||
996 | ‡2 CAOONL|ncf10262557 | ||
996 | ‡2 BLBNB|001457351 | ||
996 | ‡2 LC|nb2011011918 | ||
996 | ‡2 J9U|987007366993505171 | ||
996 | ‡2 ISNI|0000000433808380 | ||
996 | ‡2 LC|n 85104496 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |